FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/09/073278 [Registered on: 03/09/2024] Trial Registered Prospectively
Last Modified On: 21/10/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   Evaluating the Efficacy of Ayurvedic Formulation INS 00l in Treating Insomnia 
Scientific Title of Study   To determine the efficacy of an Ayurvedic formulation INS00l in treating Insomnia disorder A pilot feasibility study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Yogeshwar Chippa 
Designation  Ayurveda Research Scientist 
Affiliation  Sri Sri Institue of Advanced Research 
Address  Room no 3 Dept of Ayurveda Sri Sri Institue of Advanced Research. 21st KM kanakapura road Bangalore Karnataka

Bangalore Rural
KARNATAKA
560082
India 
Phone  9975264201  
Fax    
Email  yogeshwar.chippa@ssiar.org  
 
Details of Contact Person
Scientific Query
 
Name  Dr Yogeshwar Chippa 
Designation  Ayurveda Research Scientist 
Affiliation  Sri Sri Institue of Advanced Research 
Address  Room no 3 Dept of Ayurveda Sri Sri Institue of Advanced Research. 21st KM kanakapura road Bangalore Karnataka

Bangalore Rural
KARNATAKA
560082
India 
Phone  9975264201  
Fax    
Email  yogeshwar.chippa@ssiar.org  
 
Details of Contact Person
Public Query
 
Name  Dr Yogeshwar Chippa 
Designation  Ayurveda Research Scientist 
Affiliation  Sri Sri Institue of Advanced Research 
Address  Room no 3 Dept of Ayurveda Sri Sri Institue of Advanced Research. 21st KM kanakapura road Bangalore Karnataka


KARNATAKA
560082
India 
Phone  9975264201  
Fax    
Email  yogeshwar.chippa@ssiar.org  
 
Source of Monetary or Material Support  
Sri Sri Institute for advanced research (SSIAR) Room no 3 Dept of Ayurveda Sri Sri Institue of Advanced Research. 21st KM kanakapura road Bangalore Karnataka 560082 
 
Primary Sponsor  
Name  Sri Sri Institute for advanced research SSIAR 
Address  Ved Vignan Maha Vidya Peeth, 21st Km Kanakapura Rd,Udayapura, Bengaluru, Karnataka 560082 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Yogeshwar Chippa  Sri Sri Institute for Advanced Research  Room no 3. Dept of Ayurveda, SSIAR. 21st KM kanakapura road Bangalore Karnataka 560082
Bangalore Rural
KARNATAKA 
9975264201

yogeshwar.chippa@ssiar.org 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sri Sri Institute for advanced research (SSIAR)   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:F519||Sleep disorder not due to a substance or known physiological condition, unspecified. Ayurveda Condition: NIDRANASAH/ASVAPNAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Tab INS001, Reference: NA, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/Tablets, Dose: 1000(mg), Frequency: hs, Bhaishajya Kal: Adhobhakta, Duration: 30 Days, anupAna/sahapAna: Yes(details: -luke warm water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Male and Female participant above 18 to 60 years of age and willing to give written inform Consent.
2.Perceived total sleep time of more than 6 hours per night
3.Patient with history of self-reported primary insomnia or with diagnosis of primary insomnia (as defined by the Diagnostic and Statistical Manual for Mental Disorders-IV. 
 
ExclusionCriteria 
Details  1.Female who are pregnant, breast feeding or not
willing to use adequate contraception during the
course of the study.
2.Patient with psychiatric illness or concomitant
disorder or any other condition that could
potentially disturb or have impact on sleep.
3.Patients using tobacco products or caffeinated
beverages during night awakenings.
4.Patients on any medication for insomnia.
5.Patients using any sedative hypnotic drugs
including benzodiazepines, non-benzodiazepine
synthetic drugs, herbal and OTC products.
6.Patients working in night shifts within 5 days
of screening or intended to do so during the
course of the study.
7.Patients with history of alcohol abuse or drugs
abuse.
8.Patients who were using any other medication
that are known to influence sleep but could not be
withdrawn.
9.Patients who are participated in another
investigational drug had been used within three
months prior to screening in this study.
10.Patients who could not be relied upon to
comply with the study procedures. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in Sleep duration and Sleep quality.  Day0,Day15,Day30. 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the sleep quality of individuals under Ayurveda medication.  Day0,Day15,Day30. 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "33"
Final Enrollment numbers achieved (India)="33" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/09/2024 
Date of Study Completion (India) 21/10/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="1"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Insomnia is a major public health problem and sleep disturbance is most common in both adults and children. It is the difficulty in initiating and maintaining sleep or both, or the perception of poor sleep quality, in which the patient’s physical,psychological and social activities are interfered with, by a strong feeling of sleep deficiency upon waking in the morning.Insomnia is one among the 7 categories of sleep disorders in the International Classification of Sleep Disorders-3 (ICSD-3(2020). In Ayurveda, Nidra has been given prime importance and hence included in the tripods of life. So alteration in the natural process of nidra has a huge impact on the life processes as well. These alterations include nidranasa (complete loss of sleep), alpanidra (partial loss of sleep), nidradhikya (excess sleep) etc.Nidranasa, alpanidra, nidradhikya are vata, pitta, kapha nanatmaja vyadhis respectively. The expected outcomes are to evaluate the efficacy of Tablet INS001 in patients suffering from Insomnia and to evaluate the sleep quality of individuals under Ayurveda medication. The outcome measure would be the psychometric assessment of sleep quality using PSQI comparing Pre vs Post intervention.
 
Close